Immunovant (IMVT) awards RSUs and stock options to director Jake Bauer
Rhea-AI Filing Summary
Immunovant, Inc. director Jake Bauer reported receiving new equity awards as part of his compensation. On April 7, 2026 he was granted 13,880 shares of Common Stock in the form of restricted stock units under the company’s 2019 Equity Incentive Plan. These RSUs vest in full on April 1, 2027, conditional on his continuous service, and each unit converts into one share, with an option to defer settlement under Rule 409A. He also received a stock option for 7,061 shares at an exercise price of $24.61 per share, expiring April 7, 2036, which will vest on April 1, 2027 on the same service condition. Following the stock grant, he directly owns 38,896 shares of Immunovant common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 13,880 shares
Net Buy
2 txns
Insider
Bauer Jake
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 7,061 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 13,880 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 7,061 shares (Direct);
Common Stock — 38,896 shares (Direct)
Footnotes (2)
- F1. These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest in full on April 1, 2027, subject to the Reporting Person's continuous service to the Issuer as of such date. The Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.
- F2. These options were granted pursuant to the Plan. The shares underlying the options will vest on April 1, 2027, subject to the Reporting Person's continuous service to the Issuer as of such date.
Key Figures
RSU grant: 13,880 shares
Stock option size: 7,061 shares
Option exercise price: $24.61 per share
+3 more
6 metrics
RSU grant
13,880 shares
Restricted stock units granted April 7, 2026; vest April 1, 2027
Stock option size
7,061 shares
Option grant on April 7, 2026; vest April 1, 2027
Option exercise price
$24.61 per share
Exercise price for 7,061-share stock option grant
Option expiration
April 7, 2036
Expiration date of granted stock option
Shares held after grant
38,896 shares
Common stock directly owned after RSU grant
RSU vesting date
April 1, 2027
Full vesting date for 13,880 RSUs, subject to service
Key Terms
restricted stock units, 2019 Equity Incentive Plan, Rule 409A, continuous service
4 terms
restricted stock units financial
"These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
2019 Equity Incentive Plan financial
"These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan")."
Rule 409A financial
"The Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A."
continuous service financial
"The RSUs will vest in full on April 1, 2027, subject to the Reporting Person's continuous service to the Issuer"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transactions did Immunovant (IMVT) director Jake Bauer report?
Jake Bauer reported receiving equity awards, not open-market trades. He was granted 13,880 restricted stock units and a stock option for 7,061 shares at a $24.61 exercise price, both tied to future vesting and continuous service with Immunovant.
When do Jake Bauer’s Immunovant (IMVT) RSUs and options vest?
Both the restricted stock units and the stock options granted to Jake Bauer vest in full on April 1, 2027. Vesting is conditioned on his continuous service with Immunovant through that date, aligning his compensation with longer-term company performance and tenure.
What are the terms of Jake Bauer’s Immunovant (IMVT) stock option grant?
The stock option covers 7,061 Immunovant shares at a $24.61 exercise price and expires on April 7, 2036. The underlying shares vest on April 1, 2027, contingent on Bauer’s continued service, providing long-dated equity incentives tied to the company’s future value.
How do Jake Bauer’s Immunovant (IMVT) RSUs work under the 2019 Equity Incentive Plan?
Each of the 13,880 RSUs represents a right to receive one Immunovant share once vested. They vest in full on April 1, 2027 if Bauer remains in continuous service, and he may elect to defer settlement of vested units, subject to Rule 409A requirements.